"Bath salts" and the return of Serotonin syndrome

Journal of Clinical Psychiatry

Volumn 73, Issue 8, 2012, Pages 1126-1127

  Rasimas, J J ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' METHYLMETHCATHINONE; BENZODIAZEPINE DERIVATIVE; CATHINONE; COCAINE; METHYLONE; PHENCYCLIDINE; SEROTONIN UPTAKE INHIBITOR;

ACIDOSIS; AGITATION; CATHA EDULIS; DELIRIUM; DYSPHORIA; HALLUCINOSIS; HUMAN; HYPERREFLEXIA; HYPERTENSION; HYPERTHERMIA; KIDNEY DISEASE; MUSCLE HYPERTONIA; NOTE; PARANOIA; PRIORITY JOURNAL; PSYCHOSIS; RHABDOMYOLYSIS; SEROTONIN SYNDROME; SUBSTANCE ABUSE; TACHYCARDIA; TOXICITY TESTING;

EID: 84865740630     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12com07965     Document Type: Note

References (13)

1. Spiller HA, Ryan ML, Weston RG, et al. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila). 2011;49(6):499-505. doi:10.3109/1563650.201.590812 PubMed
2. Joksovic P, Mellos N, van Wattum PJ, et al. "Bath salts"-induced psychosis and serotonin toxicity. J Clin Psychiatry. 2012;73(8):1125.
3. Levenson JL, ed. Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill. Washington, DC: APA Publishing; 2011.
4. Tasman A, Kay J, Lieberman JA, et al, eds. Psychiatry. West Sussex, England: John Wiley and Sons; 2008. doi:10.102/9780470515167
5. Kirschner RI, Cimikoski WJ, Donovan JW. Drug combinations associated with serotonin syndrome in patients admitted to a toxicology treatment center. Clin Toxicol. 2008;46:612.
6. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120. doi:10.1056/NEJMra041867 PubMed
7. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635-642. doi:10.1093/qjmed/hcg109 PubMed
8. Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila). 2011;49(8):705-719. doi:10.3109/1563650.201.615318 PubMed
9. Dickson AJ, Vorce SP, Levine B, et al. Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. J Anal Toxicol. 2010;34(3):162-168. PubMed
10. Lusthof KJ, Oosting R, Maes A, et al. A case of extreme agitation and death after the use of mephedrone in the Netherlands. Forensic Sci Int. 2011;206(1-3):e93-e95. doi:10.1016/j.forscint.2010.12.014 PubMed
11. Maskell PD, De Paoli G, Seneviratne C, et al. Mephedrone (4-methylmethcathinone)-related deaths. J Anal Toxicol. 2011;35(3):188-191. doi:10.1093/anatox/35.3.18 PubMed
12. Murray BL, Murphy CM, Beuhler MC. Death following recreational use of designer drug "bath salts" containing 3,4-methylenedioxypyrovalerone (MDPV). J Med Toxicol. 2012;8(1):69-75. doi:10.107/s13181-01-0196-9 PubMed
13. Winstock A, Mitcheson L, Ramsey J, et al. Mephedrone: use, subjective effects and health risks. Addiction. 2011;106(11):1991-1996.